Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Healthy
Interventions
DRUG

PF-04308515

10 mg extemporaneous preparation of oral solution predosed 8 hours prior to Oral Glucose Tolerance Test(OGTT)

DRUG

PF-04308515

10 mg extemporaneous preparation of oral solution predosed 12 hours prior to Oral Glucose Tolerance Test(OGTT)

DRUG

Prednisone

5 mg tablet predosed at 8 hours prior to Oral Glucose Tolerance Test (OGTT)

DRUG

PF-04308515

X mg of Pf-04308515 extemporaneous oral solution predosed at selected time from Part 1 prior to Oral Glucose Tolerance Test (OGTT)

DRUG

PF-04308515

Y mg of Pf-04308515 extemporaneous oral solution predosed at selected time from Part 1 prior to Oral Glucose Tolerance Test (OGTT)

DRUG

Prednisone

5 mg tablet predosed at 8 hours prior to Oral Glucose Tolerance Test (OGTT)

DRUG

Prednisone

20 mg (5 mg tablets) predosed at 8 hours prior to Oral Glucose Tolerance Test (OGTT)

Trial Locations (1)

49007

Pfizer Investigational Site, Kalamazoo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY